Citation Impact
Citing Papers
Notch Pathway Inhibition Depletes Stem-like Cells and Blocks Engraftment in Embryonal Brain Tumors
2006
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
2010 StandoutNobel
BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
2003
Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition
2013
Thrombospondin 2 Potentiates Notch3/Jagged1 Signaling
2009
Hedgehog signalling in cancer formation and maintenance
2003 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Targeting cancer stem cell pathways for cancer therapy
2020
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
The 2004 World Health Organization classification of lung tumors
2005 Standout
Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
2014
Notch signaling in development and disease
2003
NOTCH2 Mutations Cause Alagille Syndrome, a Heterogeneous Disorder of the Notch Signaling Pathway
2006 Standout
The Thrombospondins
2011 Standout
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Molecular pathogenesis of lung cancer
1999
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Genetics and biomarkers in personalisation of lung cancer treatment
2013
Notch signaling in development and disease
2004
Notch3 is important for TGF-β-induced epithelial–mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1
2014
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Characterization of Notch receptor expression in the developing mammalian heart and liver
2002
Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
2005 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Predicting benefit from anti-angiogenic agents in malignancy
2006
Tumor Angiogenesis
2008 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features
2005
Molecular Pathogenesis of Lung Cancer
2002
Notch Signaling, γ-Secretase Inhibitors, and Cancer Therapy
2007
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
Works of T. P. Dang being referenced
γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer
2012
Chromosome 19 Translocation, Overexpression of Notch3, and Human Lung Cancer
2000
Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim
2009
MALDI-TOF mass spectrometry proteomic profiling to discriminate response to the combination of bevacizumab and erlotinib in non-small cell lung cancer (NSCLC)
2005